Logo-bi
Bioimpacts. 2018;8(3): 223-235. doi: 10.15171/bi.2018.25
PMID: 30211082        PMCID: PMC6128970

Review

Breast cancer vaccination comes to age: impacts of bioinformatics

Sepideh Parvizpour 1, Jafar Razmara 2, Yadollah Omidi 1,3 * ORCID

Cited by CrossRef: 25

1- Parvizpour S, Masoudi-Sobhanzadeh Y, Pourseif M, Barzegari A, Razmara J, Omidi Y. Pharmacoinformatics-based phytochemical screening for anticancer impacts of yellow sweet clover, Melilotus officinalis (Linn.) Pall. Computers in Biology and Medicine. 2021;138:104921 [Crossref]
2- Arab A, Yazdian-Robati R, Behravan J. HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development. Arch Immunol Ther Exp. 2020;68(1) [Crossref]
3- Putting into Perspective the Future of Cancer Vaccines: Targeted Immunotherapy. EMJ. 2020; [Crossref]
4- Abbaspour M, Akbari V. Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence. Expert Review of Vaccines. 2022;21(3):337 [Crossref]
5- Zarean Shahraki S, Azizmohammad Looha M, Mohammadi kazaj P, Aria M, Akbari A, Emami H, Asadi F, Akbari M. Time-related survival prediction in molecular subtypes of breast cancer using time-to-event deep-learning-based models. Front Oncol. 2023;13 [Crossref]
6- Rahman M, Masum M, Talukder A, Akter R. An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers. Informatics in Medicine Unlocked. 2023;37:101169 [Crossref]
7- Parvizpour S, Pourseif M, Razmara J, Rafi M, Omidi Y. Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches. Drug Discovery Today. 2020;25(6):1034 [Crossref]
8- Masum M, Ferdous J, Lokman S, Siddiki A. Designing of a multiepitope-based chimeric vaccine against dengue virus serotype 3 (DENV-3) through next generation reverse vaccinology approaches. Informatics in Medicine Unlocked. 2024;44:101422 [Crossref]
9- Masoudi-Sobhanzadeh Y, Jafari B, Parvizpour S, Pourseif M, Omidi Y. A novel multi-objective metaheuristic algorithm for protein-peptide docking and benchmarking on the LEADS-PEP dataset. Computers in Biology and Medicine. 2021;138:104896 [Crossref]
10- Izadi S, Nikkhoo A, Hojjat-Farsangi M, Namdar A, Azizi G, Mohammadi H, Yousefi M, Jadidi-Niaragh F. CDK1 in Breast Cancer: Implications for Theranostic Potential. ACAMC. 2020;20(7):758 [Crossref]
11- Mahdevar E, Safavi A, Abiri A, Kefayat A, Hejazi S, Miresmaeili S, Iranpur Mobarakeh V. Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches. Journal of Biomolecular Structure and Dynamics. 2022;40(14):6363 [Crossref]
12- G P, Rathi B, Santoshi S. Translational and structural vaccinomics approach to design a multi-epitope vaccine against NOL4 autologous antigen of small cell lung cancer. Immunol Res. 2023;71(6):909 [Crossref]
13- Baral P, Pavadai E, Zhou Z, Xu Y, Tison C, Pokhrel R, Gerstman B, Chapagain P. Immunoinformatic screening of Marburgvirus epitopes and computational investigations of epitope-allele complexes. International Immunopharmacology. 2022;111:109109 [Crossref]
14- Mohammadzadeh R, Soleimanpour S, Pishdadian A, Farsiani H. Designing and development of epitope-based vaccines againstHelicobacter pylori. Critical Reviews in Microbiology. 2022;48(4):489 [Crossref]
15- Zadsafar F, Tabrizchi H, Parvizpour S, Razmara J, Lotfi S. A model for mesothelioma cancer diagnosis based on feature selection using Harris hawk optimization algorithm. Computer Methods and Programs in Biomedicine Update. 2022;2:100078 [Crossref]
16- Russo G, Reche P, Pennisi M, Pappalardo F. The combination of artificial intelligence and systems biology for intelligent vaccine design. Expert Opinion on Drug Discovery. 2020;15(11):1267 [Crossref]
17- Jeevanandam J, Sabbih G, Tan K, Danquah M. Oncological Ligand-Target Binding Systems and Developmental Approaches for Cancer Theranostics. Mol Biotechnol. 2021;63(3):167 [Crossref]
18- Safavi A, Kefayat A, Abiri A, Mahdevar E, Behnia A, Ghahremani F. In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Molecular Immunology. 2019;112:93 [Crossref]
19- Zhao J, Huang J. Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1. 2020;133(7):853 [Crossref]
20- Parvizpour S, Razmara J, Pourseif M, Omidi Y. In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens. Bioimpacts. 2018;9(1):45 [Crossref]
21- Bae J, Parayath N, Ma W, Amiji M, Munshi N, Anderson K. BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications. Leukemia. 2020;34(1):210 [Crossref]
22- Pastor Y, Ghazzaui N, Hammoudi A, Centlivre M, Cardinaud S, Levy Y. Refining the DC-targeting vaccination for preventing emerging infectious diseases. Front Immunol. 2022;13 [Crossref]
23- Salehi M, Razmara J, Lotfi S, Mahan F. A One-Dimensional Probabilistic Convolutional Neural Network for Prediction of Breast Cancer Survivability. 2021; [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge